Digital health · AI in psychiatry
Legion Health
An AI native psychiatry clinic holding the second agreement Utah has ever signed to let software authorize a prescription renewal. The agreement is narrow, it lasts twelve months, and the state’s own record says the test had not started as of early September 2026.
Fifteen medicines and a waiting list
A patient in Utah who is already stable on sertraline opens an app. She is told, before anything else, that she is talking to an AI. She verifies who she is and proves she holds the prescription, in some cases by photographing the pill bottle label. Then the questions: symptoms, side effects, whether the drug is working, and finally suicidal thoughts, self harm, severe reactions, pregnancy. The New York Post described a two minute safety review. If nothing trips a flag the refill goes to her pharmacy. If something does, a clinician takes the case.
That is the entire product, and it is worth being precise about how small it is, because the claims around it are not. The system can renew only fifteen lower risk maintenance medications already prescribed by a clinician, according to The Verge, which read the agreement. It cannot start a medication, change a dose, or touch a controlled substance. Benzodiazepines, antipsychotics and lithium are all excluded, which puts most complex psychiatric cases outside it. Anyone with a recent dose change or a psychiatric hospitalization in the past year is ineligible, and every patient sees a human after ten refills or six months.
What Utah actually signed
The document is a regulatory mitigation agreement under Utah’s Artificial Intelligence Policy Act, administered by the Office of Artificial Intelligence Policy and co-signed by the Division of Professional Licensing. It is published on a state website.
The relief is not a license. The Division agreed not to bring an enforcement action for unlicensed conduct or under state telehealth rules where the AI authorizes a renewal a prescriber would otherwise sign personally. Everything not named still applies. The state says so on the same page: “An agreement is not permission to do whatever the company likes.” Participation, it adds, is not an endorsement.
In exchange Legion promised a graduated rollout. A clinician reviews the first 250 requests before any completes. The next 1,000 get retrospective review. Monthly sampling and audit follow, with reports to the state carrying “agreement rates between the AI and the reviewing clinician,” plus “Malpractice insurance that covers AI related liability.”
The access argument, and the objection
Utah is a defensible place to try this. All 29 counties are designated health professional shortage areas, and state officials said the gap leaves 500,000 residents without access to mental health care.
The psychiatrists who read the pilot were not persuaded that refills are the bottleneck. Brent Kious of the University of Utah School of Medicine told The Verge that an eligible patient already has a psychiatrist and a plan, so the tool is unlikely to reach those furthest from care, and warned it could feed an “epidemic of over-treatment.” John Torous of Beth Israel Deaconess Medical Center made the mirror point: maintenance medication deserves review, not automation.
Three roommates and a policy desk
Yash Patel, Arthur MacWaters and Daniel Wilson met at Princeton, were roommates, and have known each other twelve years. Patel worked on Medicare and Medicaid payment policy at the Congressional Budget Office, Wilson came from Microsoft, MacWaters from McKinsey. A founder profile site reports Patel was a caregiver for his father during a glioblastoma diagnosis.
They entered Y Combinator in 2021 with a different company: a marketplace helping other behavioral health organizations scale operations. It raised $2 million. Then they decided to run the clinic themselves. In October 2024 they announced $6.3 million and relaunched as an AI native practice, telling Behavioral Health Business the round had no true lead and naming Alumni Ventures, Y Combinator, Acequia Capital and Soma Capital, with angels including Ravi Shah, Erica Johnson and Jay Desai. Utah signed on March 19, 2026. The press followed that week. The money followed in June.
What is proven, and what is still claimed
| Evidence | What the record shows | Source type |
|---|---|---|
| Utah agreement | Signed Mar 19, 2026, co-signed by the Division of Professional Licensing, twelve month term. Relief covers only enforcement of unlicensed conduct and telehealth provisions against an AI authorized renewal. | Public record |
| Status | The state pilots page, updated Sep 3, 2026, lists Legion as Approved with the term reading: “The demonstration period has not started yet.” In April the company was running a waitlist. | Public record |
| Scope | Fifteen lower risk maintenance drugs, already prescribed, stable patients only. No new prescriptions, no dose changes, no controlled substances. | Independent |
| “First company ever” | The company’s YC page claims it is the “first company ever to receive regulatory authorization to let AI prescribe psychiatric medications.” Utah’s list shows Doctronic signed a similar renewals agreement on Oct 24, 2025. The Verge called Legion the second such delegation by the state and the country. The claim holds only when narrowed to psychiatric medication. | Differs from the record |
| Oversight | First 250 requests reviewed before completion, next 1,000 retrospectively, then monthly sampling, monthly reporting of AI to clinician agreement rates, and malpractice cover for AI liability. | Public record |
| Automation | Platform “automates 95% of the administrative work” needed to deliver care. No independent measurement found. | Company-stated |
| Payer coverage | In 2024 the CEO estimated the clinic was “in-network for 99% of patients in Texas” on commercial or exchange plans. | Company-stated |
| Capital | Six Form D filings under CIK 0001916502. Distinct offerings total $22,121,434 sold, most recently $16,015,934 of $25,000,000 from 79 investors. | Public record |
| Outcomes | None published. Utah says it publishes an outcomes report where a pilot generates one. | Not found |
Read plainly: the milestone is real, documented, and narrower than the language around it. A state agreed, for one year, not to prosecute a company for letting software handle a refill a prescriber would normally sign, for fifteen medicines, for patients who already have a psychiatrist. That is a first in mental health. It is not AI practicing psychiatry, and on the September record it had not yet treated a patient under the agreement. The company calls the moment “the beginning of something much bigger than refills” and says the service “will be in every state very very quickly.” The distance between those sentences is the story.
What to watch
- Whether the demonstration period starts, and how wide the gap between signature and first patient turns out to be.
- The monthly reports to Utah. The AI to clinician agreement rate is the closest thing to an outcome this pilot will produce.
- Whether the twelve month term is extended. The statute allows two extensions and no permanent version.
- A second state, against a company statement that the service goes nationwide in 2026.
In their words
“The AI is not just a cool thing to do; it’s really meaningfully creating a margin profile for the business to allow us to treat populations that haven’t been treated before and to ensure high quality care at scale.”
Yash Patel, co-founder and CEO, Behavioral Health Business, 2024 · Independent
“The biggest risk is that they’re going to have to pay $300 out of pocket, drive two hours, and sit in an office for somebody who’s going to schedule them out two weeks to two months.”
Daniel Wilson, co-founder, New York Post, 2026 · Independent
“We see this as critical to expand access to hundreds of thousands of people in Utah who live in mental health shortage areas, as well as an important proving ground for AI in medicine.”
Arthur MacWaters, co-founder and president, to The Verge, 2026 · Independent
“Every patient is going to have AI working on their behalf in five years.”
Arthur MacWaters, New York Post, 2026 · Independent
“It would be better if there were greater transparency, more science, and more rigorous testing before people are asked to use this.”
Brent Kious, University of Utah School of Medicine, to The Verge, 2026 · Independent
“They require more active management, changes, and careful consideration.”
John Torous, Beth Israel Deaconess Medical Center, to The Verge, 2026 · Independent
“We don’t want to be AI doom or AI boomer.”
Margaret Woolley Bussee, Utah Department of Commerce, New York Post, 2026 · Independent
Related companies
Sources
- Public recordAuthorized AI Pilots
- Public recordAI Legion Health pilot page
- Public recordUtah Code 13-72-301 to 13-72-403
- Public recordForm D, Legion Health, Inc., CIK 0001916502
- Public recordForm D and Form D/A filings
- Not foundFDA 510(k), FDA PMA, ClinicalTrials.gov, NIH RePORTER and PubMed searches
- IndependentThis chatbot can prescribe psych meds. Kind of.
- IndependentArtificial intelligence will see you now: Bots to prescribe mental health drugs
- IndependentStartup Approved to Let AI System Prescribe Psychiatric Medication
- IndependentLegion Health Pivots to Digital AI-Enabled Psychiatry, Raises Over $6M
- IndependentUtah’s AI Regulatory Learning Laboratory
- IndependentUtah Shows How States Should Regulate AI in Healthcare
- IndependentLegion Health raises $16M of planned $25M round
- ProfileFerdinand Martignetti, Nava Ventures II
- CompanyLegion Health company page and launch post
- CompanyLegion Health website and FAQ
Profile researched and written by Healthcare Discovery. Last updated September 29, 2026.
